NanoViricides
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NanoViricides generated cash of -$6,315,507, which is less than the previous year. Cash used in financing activities reached the amount of $3,120,037 last year. Net change in cash is therefore -$3,352,030.
Cash Flow
| 2015 | -6.21M | -5.76M | 6.74K |
|---|---|---|---|
| 2016 | -6.82M | -476.36K | 0 |
| 2017 | -7.89M | -164.97K | -1M |
| 2018 | -7.77M | -241.82K | 4.60M |
| 2019 | -6.80M | -73.79K | 2.35M |
| 2020 | -6.66M | -8.63K | 17.82M |
| 2021 | -8.21M | -238.76K | 15.26M |
| 2022 | -5.89M | -324.34K | -234.71K |
| 2023 | -5.67M | -151.71K | -94.78K |
| 2024 | -6.31M | -156.56K | 3.12M |
NNVC Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.14M | 14.06M | 20.51M | 13.70M | 2.55M | 7.08M | 15.09M | 24.16M | 31.46M | 36.69M |
Operating activities | ||||||||||
Net income | -8.29M | -8.58M | -8.10M | -8.82M | -13.44M | -8.42M | -8.56M | -10.30M | -10.72M | -2.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 759.01K | 747.52K | 723.32K | 704.53K | 699.72K | 695.91K | 680.05K | 662.95K | 659.54K | 302.73K |
Stock-based compensation expense | 222.18K | 214.17K | 338.41K | 405.59K | 559.39K | 532.32K | 0 | 1.60M | 1.22M | 1.15M |
| Deferred income tax benefit | 222.18K | 214.17K | 338.41K | 405.59K | 559.39K | 532.32K | 0 | 1.60M | 1.22M | 1.15M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 705.81K | 118.13K | 40.80K | -710.75K | 110.63K | 802.86K | -145.67K | -387.49K | 458.26K | -286.93K |
Cash generated by operating activities | -6.31M | -5.67M | -5.89M | -8.21M | -6.66M | -6.80M | -7.77M | -7.89M | -6.82M | -6.21M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -156.56K | -151.71K | -324.34K | -238.76K | -8.63K | -73.79K | -241.82K | -164.97K | -476.36K | -6.76M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -156.56K | -151.71K | -324.34K | -238.76K | -8.63K | -73.79K | -241.82K | -164.97K | -476.36K | -5.76M |
Financing activities | ||||||||||
Common Stock Issued | 3.12M | 0 | 0 | 16.56M | 16.67M | 2.35M | 4.60M | 5M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -94.78K | -234.71K | -1.30M | -92.33K | 0 | 0 | -1M | 0 | 0 |
Cash used in financing activities | 3.12M | -94.78K | -234.71K | 15.26M | 17.82M | 2.35M | 4.60M | -1M | 0 | 6.74K |
Net Change In Cash | -3.35M | -5.91M | -6.45M | 6.80M | 11.15M | -4.52M | -8.01M | -9.06M | -7.30M | -5.22M |
Cash at end of period | 4.79M | 8.14M | 14.06M | 20.51M | 13.70M | 2.55M | 7.08M | 15.09M | 24.16M | 31.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |